The U.S. Food and Drug Administration (FDA) has granted an expanded interchangeable designation for Celltrion’s YUFLYMA.

FDA approved Vyvgart Hytrulo prefilled syringe for gMG and CIDP self-injection in 20–30 seconds. Human factor studies showed patients and caregivers safely administered the new formulation.

(MENAFN- GlobeNewsWire - Nasdaq) The global market for prefilled syringes is expanding, driven by the rising prevalence of chronic illnesses, greater use of biologics and biosimilars, and a ...

The global market for prefilled syringes is expanding, driven by the rising prevalence of chronic illnesses, greater use of biologics and biosimilars, and a growing trend toward self-injection.

The global market for prefilled syringes is expanding, driven by the rising prevalence of chronic illnesses, greater use of biologics and biosimilars, and a growing trend toward self-injection.

The South Korea prefilled syringes market is expected to grow at a CAGR of 4.32% from 2024 to 2032, driven by rising chronic diseases, stricter regulation, etc. TOKYO, JAPAN, April 1, 2025 ...

Dublin, March 18, 2025 (GLOBE NEWSWIRE) -- The "Prefilled Syringes Market Industry Report 2025, by Purpose of Syringe, Therapeutic Area, Type of Molecule, Type of Barrel Material, Number of Barrel ...

The new single-dose prefilled syringes will be available in 40 USP units/0.5mL and 80 USP units/mL dosage strengths. The Food and Drug Administration (FDA) has approved Purified Cortrophin ® Gel ...

The new prefilled syringe has the same composition but removes the need for reconstitution. The Food and Drug Administration (FDA) has accepted for review the regulatory application for a new ...

Please provide your email address to receive an email when new articles are posted on . The European Medicines Agency approved the Vabysmo 6 mg prefilled syringe for three retinal conditions ...